AMO Pharma Presents Statistical Analysis of Results of Phase 2 Study of AMO-02 in Adolescents with Autism Spectrum Disorder content= - PR Newswire UK

Submitted by Anonymous (not verified) on Mon, 05/06/2019 - 14:45

AMO Pharma Presents Statistical Analysis of Results of Phase 2 Study of AMO-02 in Adolescents with Autism Spectrum Disorder content=  PR Newswire UKResults highlighting consistent patterns in efficacy across multiple outcomes measures presented at International Society for Autism Research Annual Meeting in ...